跳至主要内容
临床试验/NCT03477266
NCT03477266已完成3 期

Effectiveness of Mouth Dissolving Mosapride Tablets on Enhancing Gut Recovery After Cesarean Section: Randomized Double-blind, Placebo-controlled Clinical Trial

Benha University1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2018年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
400
试验地点
1
主要终点
Time of first flatus

研究概览

简要总结

Giving women one day before and immediately after cesarean section a mouthly dissolving mosapride tablets 2every every 8 hours for maximum of 5 days ,or getting recovered gastrointestinal functions And assess preoperative gastrointestinal functions

详细描述

Uncomplicated post cesarean women one day before and immediately after elective cesarean receive 2 mouthly dissolving mosapride tablets every 8 hours maximum for 5 days and clinical care giver follow the woman's gastrointestinal functions, including intraoperative and postoperative nausea vomiting, passing flatus, hearing intestinal sounds, passing stools, occurring of paralytic ileus, length of the hospital stay

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

盲法说明

Color coded active tablets backed in red while identical dummy tablets coded in blue,both tablets are physically identical and usually no anticipated noticed side effects from mosapride

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • all women undergoing elective cesarean section

排除标准

  • prior abdominal surgery, abdominal adhesion, chronic constipation, allergy to mosapride

研究组 & 干预措施

Mouth dissolving mosapride

Experimental

Fluxopride 5mg of Macryrl egypt 2 tablets one day before and immediately after elective cesarean section every 8hour for maximum of 5 days

干预措施: Mosapride (Drug)

Placebo mouth dissolving tablets

Placebo Comparator

Dummy identical tablets taken in the same way

干预措施: Placebo Oral Tablet (Drug)

结局指标

主要结局

Time of first flatus

时间窗: 96 hours postoperative

Clinical

次要结局

  • Paralytic ileus incidence and its severity(7days)
  • Toleration of fluids and solids intake(2 weeks postoperative)
  • Incidence of intraoperative and postoperative nausea and vomiting(Intraoperative and 2 weeks postoperative)
  • First defecation(2 weeks postoperative)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

ashraf nassif mahmoud elmantwe,MD

Assistant professor

Benha University

研究点 (1)

Loading locations...

相似试验